NY AG Stops Harm To Alzheimer's Patients — For Now

Law360, New York ( January 14, 2015, 10:41 AM EST) -- Controlling drug costs, especially increases in drug costs, is critical for the nation's economic survival. Antitrust enforcement has played a critical role in the past decade preventing anti-competitive conduct that would otherwise increase drug prices or hamper price decreases. Essential to this effort is protecting the opportunities for competition from generic drugs, which typically cost less than 20 percent of a comparable branded drug. This is why states have enacted laws to preserve the ability of pharmacists to easily substitute generic drugs....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!